| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 18898 |
| 1 | DEXAMETHASONE | 11607 |
| 2 | DEXAMETHASONE 1.5 MG | 11600 |
| 3 | CYCLOPHOSPHAMIDE | 10581 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 10581 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10581 |
| 6 | LENALIDOMIDE | 9297 |
| 7 | RITUXIMAB | 8271 |
| 8 | CARBOPLATIN | 7436 |
| 9 | PALBOCICLIB | 6728 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOZAPINE | 18898 | 0.1514 |
| 1 | ERIBULIN MESYLATE | 537 | 0.1444 |
| 2 | RIBOCICLIB | 4093 | 0.1304 |
| 3 | SACITUZUMAB GOVITECAN | 510 | 0.1129 |
| 4 | DEXRAZOXANE FOR INJECTION | 104 | 0.1121 |
| 5 | TRABECTEDIN | 248 | 0.1074 |
| 6 | GRANULOCYTE COLONY STIMULATING FACTOR | 216 | 0.0990 |
| 7 | PEGFILGRASTIM | 1155 | 0.0986 |
| 8 | VINORELBINE | 668 | 0.0972 |
| 9 | LETROZOLE TABLETS | 4547 | 0.0951 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22267 |
| 1 | Atypical Antipsychotic [EPC] | 20950 |
| 2 | Platinum-based Drug [EPC] | 15801 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 14121 |
| 4 | Alkylating Drug [EPC] | 13946 |
| 5 | Thalidomide Analog [EPC] | 12278 |
| 6 | Kinase Inhibitor [EPC] | 10525 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 9019 |
| 8 | Microtubule Inhibitor [EPC] | 8419 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8379 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 524 | 0.0935 |
| 1 | Leukocyte Growth Factor [EPC] | 4720 | 0.0844 |
| 2 | Topoisomerase Inhibitor [EPC] | 5323 | 0.0695 |
| 3 | Estrogen Receptor Antagonist [EPC] | 2492 | 0.0626 |
| 4 | Platinum-based Drug [EPC] | 15801 | 0.0592 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1281 | 0.0586 |
| 6 | Alkylating Drug [EPC] | 13946 | 0.0582 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 212 | 0.0580 |
| 8 | Actinomycin [EPC] | 126 | 0.0575 |
| 9 | CD30-directed Immunoconjugate [EPC] | 586 | 0.0575 |